Corcept Therapeutics Incorporated
CORT
$71.38
$0.921.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -21.42% | 4.10% | 7.07% | 30.25% | -11.68% |
| Total Receivables | -2.67% | -2.08% | 25.42% | 19.05% | 33.28% |
| Inventory | 99.83% | 60.57% | 7.15% | 20.75% | 12.19% |
| Prepaid Expenses | -60.94% | 119.77% | -15.31% | -66.27% | 48.26% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -46.70% | -- | -- | -- |
| Total Current Assets | -12.89% | 2.83% | 8.22% | 29.65% | -5.72% |
|
|
|||||
| Total Current Assets | -12.89% | 2.83% | 8.22% | 29.65% | -5.72% |
| Net Property, Plant & Equipment | 3,990.43% | 2,443.81% | 1,656.88% | 1,004.32% | -81.85% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.79% | 33.89% | 38.23% | 39.23% | 35.20% |
| Total Assets | 29.05% | 35.24% | 32.02% | 36.20% | 6.16% |
|
|
|||||
| Total Accounts Payable | 122.56% | -11.61% | 11.21% | 144.28% | 11.96% |
| Total Accrued Expenses | 57.19% | 73.22% | 66.56% | 49.87% | 61.90% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,194.74% | 449.01% | 92.00% | -85.19% | -86.78% |
| Total Finance Division Other Current Liabilities | -72.27% | -85.04% | -83.76% | -84.48% | -39.01% |
| Total Other Current Liabilities | -72.27% | -85.04% | -83.76% | -84.48% | -39.01% |
| Total Current Liabilities | 47.18% | 34.70% | 3.56% | 8.26% | 23.25% |
|
|
|||||
| Total Current Liabilities | 47.18% | 34.70% | 3.56% | 8.26% | 23.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 31.13% | 36.64% | 22.70% | 19.95% | 15.64% |
| Total Liabilities | 50.98% | 40.20% | 9.88% | 14.85% | 22.44% |
|
|
|||||
| Common Stock & APIC | 13.80% | 12.67% | 11.62% | 12.26% | 11.53% |
| Retained Earnings | 31.14% | 35.08% | 38.21% | 37.08% | 37.80% |
| Treasury Stock & Other | -16.10% | -9.76% | -7.69% | -5.97% | -38.50% |
| Total Common Equity | 24.72% | 34.12% | 38.37% | 41.42% | 3.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.72% | 34.12% | 38.37% | 41.42% | 3.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 24.72% | 34.12% | 38.37% | 41.42% | 3.45% |
|
|
|||||